These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8439265)

  • 21. [A case of Hallervorden-Spatz disease with magnetic resonance imaging data].
    Ruiz-Sandoval JL; García-Ramos G; Vega-Boada F; Estañol-Vidal B
    Rev Invest Clin; 1998; 50(3):249-53. PubMed ID: 9763892
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Psychosis as presenting symptom in adult-onset Hallervorden-Spatz syndrome.
    Panas M; Spengos K; Koutsis G; Tsivgoulis G; Sfagos K; Kalfakis N; Vassilopoulos D
    Acta Neuropsychiatr; 2007 Apr; 19(2):122-4. PubMed ID: 26952824
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hallervorden Spatz disease: MR imaging.
    Shah J; Patkar D; Patankar T; Krishnan A; Prasad S; Limdi J
    J Postgrad Med; 1999; 45(4):114-7. PubMed ID: 10734349
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The Hallervorden-Spatz sickness with reticular and cerebellar participation in the aged].
    Evrard E; Hariga J; Martin JJ; Reznik M
    Rev Neurol (Paris); 1967 Jun; 116(6):693. PubMed ID: 5619764
    [No Abstract]   [Full Text] [Related]  

  • 25. First cases in the Czech Republic of the Hallervorden-Spatz disease resulting from mutation in the pantothenate kinase 2 gene.
    Zumrová A; Krepelová A; Kyncl M; Maríková T; Prosková M; Cíbochová R; Sebronová V; Komárek V
    Neuro Endocrinol Lett; 2005 Jun; 26(3):213-8. PubMed ID: 15990724
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Psychotic disorder in a case with Hallervorden-Spatz disease.
    Oner O; Oner P; Deda G; Içağasioğlu D
    Acta Psychiatr Scand; 2003 Nov; 108(5):394-7; discussion 397-8. PubMed ID: 14531762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hallervorden-Spatz syndrome resembling a typical Tourette syndrome.
    Scarano V; Pellecchia MT; Filla A; Barone P
    Mov Disord; 2002 May; 17(3):618-20. PubMed ID: 12112223
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Late Hallervorden-Spatz disease with important reticular and cerebellar participation].
    Evrard E; Hariga J; Martin JJ; Reznik M
    Psychiatr Neurol Neurochir; 1968; 71(3):243-54. PubMed ID: 5687405
    [No Abstract]   [Full Text] [Related]  

  • 29. Pantothenate kinase associated neurodegeneration (Hallervorden-Spatz syndrome).
    Kapoor S; Hortnagel K; Gogia S; Paul R; Malhotra V; Prakash A
    Indian J Pediatr; 2005 Mar; 72(3):261-3. PubMed ID: 15812126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [On a pigmentary dystrophy of reticulo-dentato-nigric and cutaneo-meningeal predilection with disseminated nodular proliferative angiomatosis. (Its relation to Hallervorden-Spatz disease, its place in the cutaneo-neuraxic pigmentary syndromes)].
    van Bogaert L; Colle G
    Rev Neurol (Paris); 1967 Nov; 117(5):613-25. PubMed ID: 4880846
    [No Abstract]   [Full Text] [Related]  

  • 31. Neurodegeneration with brain iron accumulation: clinical, radiographic and genetic heterogeneity and corresponding therapeutic options.
    Clement F; Devos D; Moreau C; Coubes P; Destee A; Defebvre L
    Acta Neurol Belg; 2007 Mar; 107(1):26-31. PubMed ID: 17569231
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical features of neuroleptic malignant syndrome in basal ganglia disease. Spontaneous presentation in a patient with Hallervorden-Spatz disease in the absence of neuroleptic drugs.
    Hayashi K; Chihara E; Sawa T; Tanaka Y
    Anaesthesia; 1993 Jun; 48(6):499-502. PubMed ID: 8322990
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relaxation and susceptibility MRI characteristics in Hallervorden-Spatz syndrome.
    Vinod Desai S; Bindu PS; Ravishankar S; Jayakumar PN; Pal PK
    J Magn Reson Imaging; 2007 Apr; 25(4):715-20. PubMed ID: 17352378
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A family with Hallervorden-Spatz disease. (Contribution to the study of the so-called pure forms].
    Myle G; Fadiloglu S
    Encephale; 1967; 56(4):343-59. PubMed ID: 6057416
    [No Abstract]   [Full Text] [Related]  

  • 35. Iron in the Hallervorden-Spatz syndrome.
    Koeppen AH; Dickson AC
    Pediatr Neurol; 2001 Aug; 25(2):148-55. PubMed ID: 11551745
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A 75-year-old man with parkinsonism and sudden death].
    Nagaoka M; Nakamura N; Yamamura A; Mori H; Shirai T; Mizuno Y
    No To Shinkei; 1995 Dec; 47(12):1199-208. PubMed ID: 8534559
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hallervorden-Spatz disease.
    Boyacigil S; Tokoğlu F; Paşaoğlu E; Ardiç S; Comoğlu S; Saka M; Oztürk S
    Australas Radiol; 1996 Aug; 40(3):351-3. PubMed ID: 8826751
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hallervorden-Spatz syndrome.
    Dooling EC; Schoene WC; Richardson EP
    Arch Neurol; 1974 Jan; 30(1):70-83. PubMed ID: 4808495
    [No Abstract]   [Full Text] [Related]  

  • 39. [Hallervorden-Spatz disease in a brother and a sister (hereditary-familial fragility of the extrapyramidal apparatus)].
    de Barsy T
    J Genet Hum; 1968 Jan; 16(3):41-7. PubMed ID: 5710711
    [No Abstract]   [Full Text] [Related]  

  • 40. Enteral levodopa/carbidopa infusion in advanced Parkinson disease: long-term exposure.
    Nyholm D; Lewander T; Johansson A; Lewitt PA; Lundqvist C; Aquilonius SM
    Clin Neuropharmacol; 2008; 31(2):63-73. PubMed ID: 18382177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.